Discovery of new non-covalent and covalent inhibitors targeting SARS-CoV-2 papain-like protease and main protease
Description
Global coronavirus disease 2019 (COVID-19) pandemic still threatens human health and public safety, and the development of effective antiviral agent is urgently needed. The SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) are vital
